Exhibit 10.3


 


 CONSULTING
SERVICES AGREEMENT


 


This CONSULTING SERVICES
AGREEMENT (this “Agreement”), is dated as of March 10, 2014, 2013, by and between Skystar Bio-Pharmaceutical
Company, a Nevada corporation (the “Company”), and R. Scott Cramer, an individual, whose address is 800 N. Maitland
Ave., Suite 204, Maitland, Fl 32751 (the “Consultant”). The Company and the Consultant are collectively referred
to herein as the “Parties.”


 


RECITALS:


 


WHEREAS,
the Consultant is currently a member of the Company’s Board of Directors (the “Board”), a position
he has held since October 2001, and has been separately and additionally acting as the United States Representative of the Company
(the “Representative”) since November 2006; and


 


WHEREAS,
the Parties previously entered into an agreement setting forth the terms for the services of the Consultant as the Representative
(“Prior Consulting Agreement”), which agreement expired on March 31, 2012; and


 


WHEREAS, the Consultant, pursuant to an oral
understanding with the Company, continued his services to the Company as the Representative under certain terms since March 31,
2012 without a written renewal of the Prior Consulting Agreement or other written agreement; and


 


WHEREAS,
the Parties desire to amend, in part, and restate the Prior Consulting Agreement with certain amendments and memorialize the terms
and conditions for the Consultant’s services as the Representative as set forth in this Agreement, with the intent to supersede
any prior understanding, agreements and arrangements by and between the parties.


 


NOW, THEREFORE, in
consideration of the foregoing recitals and the mutual agreements herein contained and for other good and valuable consideration,
the Parties hereto agree as follows:


 


		1.	Continuing Services as the Representative.



 


1.1         Services Prior
to This Agreement. The Parties understand and agree that this Agreement is intended to cover Consultant’s services provided
to the Company during the term from April 1, 2012 through the date hereof.


 


1.2         Continued Services. The Consultant
shall continue to act as the Representative upon the terms and conditions set forth hereinafter, and in such capacity, shall provide
such services as set forth on attached Annex A and such other services as may be assigned to him from time to time by the
Company’s Chief Executive Officer (collectively the “Services”). As the Representative, the Consultant
shall report to the Chief Executive Officer during the Term (as defined in Section 3.1) of this Agreement.


 


2.          Compensation.
As compensation for the Services during the Term (as defined in Section 3.1) pursuant to this Agreement, the Consultant shall be
compensated as follows:


 


2.1         Cash Fee.
The Company shall pay the Consultant a fee of $7,500.00 every three calendar months. The first installment of this fee shall have
been paid on [on the first business day following the end of each three month period]. Payment will be made to the Consultant via
wire transfer, and the Company shall be responsible for any applicable wire transfer fees.


 


2.2         Equity Compensation.
The Company shall issue to the Consultant 7,000 restricted shares of common stock every three calendar months under the Company’s
2010 Stock Incentive Plan pursuant to the terms of a Restricted Stock Award Agreement in the form attached hereto as Exhibit A
(the “Restricted Stock Agreement”). The first installment of these shares shall be so issued no later than March 31,
2014 or as soon as practicable by the Company after the execution of this Agreement and subsequent issuances shall be on the last
trade day of each fiscal quarter.


 


2.3         Expenses.
The Company shall reimburse the Consultant for all reasonable business expenses incurred by the Consultant during the Term hereunder
upon presentation by the Consultant of such documentation and records as the Company shall request from time to time require, provided
that any expense in excess of $500.00 shall require the prior written approval of the Company.


 


2.4         Compensation
for Directorship. The Consultant presently serves on the Board as a Director. The Consultant acknowledges that while this Agreement
is in effect, the Consultant may be entitled to any additional compensation as a Director and any such compensation, if due, shall
be covered by a separate agreement.


 


3.          Term and Termination.


 


3.1         Term. The
term of this Agreement is commenced on the date of this Agreement and shall continue until terminated as provided herein (the “Term”).


 


3.2         Termination
upon Death. If the Consultant dies during the Term, this Agreement shall thereupon terminate, except that the Company shall
pay to the estate of the Consultant any accrued and unpaid fee due the Consultant pursuant to Section 2.1 hereof, as well as such
number of shares as provided pursuant to Section 2.2 hereof, and all previously accrued but unpaid expense reimbursements under
Section 2.3 at the time of the Consultant’s death.


 




    	1



    	 



    

 


3.3         Termination
upon Disability. The Company may terminate this Agreement upon ten (10) days’ written notice if, for a continuous or
accumulated period of forty-five (45) days during the Term, the Consultant is prevented from discharging the Services due to any
physical or mental disability. With the exception of the covenants included in Section 4 below, upon such termination, the obligations
of the Consultant and the Company under this Agreement shall immediately cease. In the event of a termination pursuant to this
section, the Consultant shall be entitled to receive any accrued and unpaid amounts earned pursuant to Section 2.1 hereof, as well
as such number of shares as provided pursuant to Section 2.2 hereof, and all previously accrued but unpaid expense reimbursements
under Section 2.3 at the time of termination.


 


3.4         Termination
for Cause. The Company reserves the right to terminate this Agreement if the Consultant willfully breaches or habitually neglects
the Services that he is required to perform under the terms of this Agreement, or if the Consultant commits such acts of dishonesty,
fraud, misrepresentation, gross negligence, or willful misconduct as would prevent the effective performance of the Services or
which results in material harm to the Company or its business. The Company may terminate this Agreement for cause by giving written
notice of termination to the Consultant. With the exception of the covenants included in Sections 4 and 5 below, upon the date
of delivery of the written notice of such termination, the obligations of the Consultant and the Company under this Agreement shall
immediately cease. Such termination shall be without prejudice to any other remedy to which the Company may be entitled either
at law, in equity, or under this Agreement. In the event of a termination pursuant to this section, the Consultant shall be entitled
to receive any accrued and unpaid amounts earned pursuant to Section 2.1 hereof pro rata through the date of such termination.
The Company shall also pay to the Consultant all previously accrued but unpaid expense reimbursements under Section 2.3 at the
time of termination. 


 


3.5         Termination
without Cause. The Company may terminate this Agreement upon not less than thirty (30) days’ written notice by the Company
to the Consultant. With the exception of the covenants included in Sections 4 and 5 below, upon such termination the obligations
of the Consultant and the Company under this Agreement shall immediately cease. In the event of a termination pursuant to this
section, the Consultant shall be entitled to receive any accrued and unpaid amounts earned pursuant to Section 2.1 hereof, as well
as such number of shares as provided pursuant to Section 2.2 hereof, and all previously accrued but unpaid expense reimbursements
under Section 2.3 at the time of termination.


 


3.6         Termination by the Consultant.
The Consultant may terminate this Agreement upon not less than thirty (30) days’ written notice by the Consultant to the
Company.


 


4.          Confidential
Information.


 


4.1         Confidential
Information. The Consultant acknowledges that:


 


4.1.1     As a result
of his association with the Company pursuant to this Agreement and otherwise, the Consultant may obtain secret and confidential
information concerning the business of the Company and its subsidiaries and affiliates (collectively, the “Group”),
including, without limitation, trade secrets and any information concerning products, processes, formulas, designs, inventions
(whether or not patentable or registrable under copyright or similar laws, and whether or not reduced to practice), discoveries,
concepts, ideas, improvements, techniques, methods, research, development and test results, specifications, data, know-how, software,
formats, marketing plans and analyses, business plans and analyses, strategies, forecasts, and customer and supplier identities,
characteristics, and agreements (“Confidential Information”). In addition, the Consultant may become aware of
business opportunities that may be beneficial to the Group, including, but not limited, opportunities to acquire or purchase, or,
except for Permitted Competitive Investments (as defined in Section 4.4), otherwise make equity or debt investments in, companies
primarily involved in a Competitive Business (“Corporate Opportunities”), during the Term, whether in the course
of performing the Services or otherwise, and that such Corporate Opportunities shall considered to be business opportunities of
the Group.


 


4.1.2     The Group
will suffer substantial damage which will be difficult to compute if, during the Term or thereafter, the Consultant should divulge
Confidential Information.


 


4.1.3     The provisions
of this Agreement are reasonable and necessary for the protection of the business of the Group.


 


4.2         Protection
of Confidential Information. The Consultant agrees that he will not at any time, either during the Term of this Agreement or
thereafter, divulge to any person or entity any Confidential Information obtained or learned by him as a result of his Services
to the Company, except (i) in the course of performing the Services, (ii) to the extent that any such information is
in the public domain other than as a result of the Consultant’s breach of any of his obligations hereunder, (iii) where
required to be disclosed by court order, subpoena, or other government process, or (iv) if such disclosure is made without
the Consultant’s knowing intent to cause material harm to the Group. If the Consultant shall be required to make disclosure
pursuant to the provisions of clause (iii) of the preceding sentence, the Consultant promptly, but in no event more than 24 hours
after learning of such subpoena, court order, or other government process, shall notify, by personal delivery or by electronic
means, confirmed by mail, the Company and, at the Company’s expense, the Consultant shall: (a) take reasonably necessary
and lawful steps required by the Group to defend against the enforcement of such subpoena, court order, or other government process,
and (b) permit the Group to intervene and participate with counsel of its choice in any proceeding relating to the enforcement
thereof.


 




    	2



    	 



    

 


4.3         Return of Confidential
Documents. Upon termination of this Agreement, the Consultant will promptly deliver to the Group all memoranda, correspondence,
notes, records, reports, manuals, drawings, blue-prints, and other documents (and all copies thereof) relating to the business
of the Group and all property associated therewith that he may then possess or have under his control during the course of performing
the Services, whether prepared by the Consultant or others.


 


4.4         Competition.
During the Term and terminating one year after the Consultant ceases to serve on the Board, the Consultant, without the prior written
permission of the Company, shall not for any reason whatsoever, (i) enter into the employ of or render any services to any person,
firm or corporation engaged in any business which is in competition with the Group’s principal existing business at the time
of termination (“Competitive Business”); (ii) engage in any Competitive Business as an individual, partner,
shareholder, creditor, director, officer, principal, agent, employee, trustee consultant, or advisor or in any other relationship
or capacity; (iii) employ, or have or cause any other person or entity to employ, any person who was employed by the Group at the
time of termination of this Agreement; or (iv) solicit, interfere with, or endeavor to entice away from the Group, for the benefit
of a Competitive Business, any of its customers. Notwithstanding the foregoing, (i) the Consultant shall not be precluded from
investing and managing the investment of, his or his family’s assets in the securities of any corporation or other business
entity that is engaged in a Competitive Business if such securities are traded on a national stock exchange or quoted on the over-the-counter
market and if such investment does not result in his beneficially owning, at any time, more than 2% of any class of the publicly
traded equity securities of such Competitive Business (“Permitted Competitive Investment”); and (ii) during
the Term of this Agreement and terminating one year after the Consultant ceases to serve on the Board (except for investments in
a class of securities trading on public markets), the Consultant: (a) shall be prohibited from taking for himself personally any
Corporate Opportunities, and (b) shall refer to the Company for consideration (before any other party) any and all Corporate Opportunities
that arise during the Term of this Agreement or for a period of one year thereafter. If the Company determines not to exploit any
Corporate Opportunity, the Company shall determine what, if anything, should be done with such opportunity. The Consultant shall
not be entitled to any compensation, as a finder or otherwise, if either the Company or the Consultant introduces such opportunity
to other persons, it being understood that any such compensation shall be paid to the Company.


 


4.5         Remedies for
the Company. If the Consultant commits a breach of any of the provisions of Section 4.2 or 4.4, the Company shall have the
right:


 


4.5.1     to have
the provisions of this Agreement specifically enforced by any court having equity jurisdiction, it being acknowledged and agreed
by the Consultant that the services being rendered hereunder to the Company are of a special, unique and extraordinary character
and that any breach or threatened breach will cause irreparable injury to the Group and that money damages will not provide an
adequate remedy to the Group;


 


4.5.2     to require
the Consultant to account for and pay over to the Company all monetary damages determined by a non-appealable decision by a court
of law to have been suffered by the Group as the result of any actions constituting a breach of any of the provisions of Section
4.2 or 4.4, and the Consultant hereby agrees to account for and pay over such damages to the Company; and


 


4.5.3     to not perform
any obligation owed to the Consultant under this Agreement, to the fullest extent permitted by law. The Company shall also have
the right, to the fullest extent permitted by law, to adjust any amount due and owing or to be due and owing to the Consultant,
whether under this Agreement or any other agreement between the Company and the Consultant in order to satisfy any losses to the
Group as a result of Consultant’s breach.


 


4.6        Violation of
Covenant. If the Consultant shall violate any covenant contained in Section 4.4, the duration of such covenant so violated
shall be automatically extended for a period of time equal to the period of such violation.


 


5.           The Consultant’s
Representations. The Consultant represents that the entering into and performance of this Agreement by will not violate any
law, rule, regulation, order, contract, or agreement to which the Consultant is a party or is bound or affected.


 


6.           Miscellaneous
Provisions.


 


6.1         Independent
Contractor Status. The Parties acknowledge and agree that the Consultant’s relationship with the Company is that of independent
contractor and not that of an employee. Nothing in this Agreement is intended to create or will be deemed to create or constitute
a joint venture or partnership between the Company and the Consultant.


 


6.2         Taxes.
The Consultant will be responsible for the payment of all withholding, payroll, and other taxes payable in respect of the payments
received by the Consultant under this Agreement and hereby agrees to indemnify and hold the Company harmless from any obligation
or penalty arising from the failure to pay such taxes.


 


6.3         Notices.
All notices provided for in this Agreement shall be in writing, and shall be deemed to have been duly given when delivered personally
to the party to receive the same, when delivered via overnight courier providing for next day delivery service (“Overnight
Courier”), when transmitted by facsimile (electronic receipt confirmed), or when mailed first class postage prepaid,
by certified mail, return receipt requested, addressed to the party to receive the same at his or its address set forth below,
or such other address as the party to receive the same shall have specified by written notice given in the manner provided for
in this Section 6.3. All notices shall be deemed to have been given: (a) as of the date of personal delivery, (b) the first business
day after delivery via Overnight Courier, (c) on the electronically confirmed date of receipt during business hours of the facsimile
transmittal (or the following business day if the facsimile is received after 5:30 p.m. Pacific Time), or (d) three calendar days
after the date of deposit (postage pre-paid) with the U.S. Postal Service if delivered via first class or certified mail.


 




    	3



    	 



    

 


	 	If to the Consultant:	
        R. Scott Cramer

        800 N. Maitland Ave.

        Suite 204

        Maitland, FL 32789-2225



 


	 	If to the Company:	
        Skystar Bio-Pharmaceutical Company

        Room 10601, Jiezuo Plaza

        No. 4, Fenghui Road South

        Gaoxin District, Xian Province, PRC

        Attn: Weibing Lu



 


6.4        Survival Provisions.
The provisions of Sections 4 and 5, and any provisions relating to payments owed to the Consultant after termination of this Agreement,
shall survive termination of this Agreement for any reason.


 


6.5        Entire Agreement.
This Agreement sets forth the entire agreement of the Parties relating to the Services of the Consultant and is intended to supersede
all prior negotiations, understandings, and agreements, whether oral or written. No provisions of this Agreement may be waived
or changed except by writing by the party against whom such waiver or change is sought to be enforced. The failure of any party
to require performance of any provision hereof or thereof shall in no manner affect the right at a later time to enforce such provision.


 


6.6        Governing Law.
All questions with respect to the construction of this Agreement, and the rights and obligations of the parties hereunder, shall
be determined in accordance with the law of the State of Delaware applicable to agreements made and to be performed entirely in
the State of Nevada. Any disputes, claims, or causes of action by one party against the other arising out of, in related to or
concerning this Agreement shall be commenced and maintained in any state or federal court located in the State of Nevada, and the
Consultant hereby submits to the jurisdiction and venue of any such court.


 


6.7        Successors
and Assigns. This Agreement shall inure to the benefit of and be binding upon the successors and assigns of the Company. This
Agreement shall not be assignable by the Consultant, but shall inure to the benefit of and be binding upon the Consultant’s
heirs and legal representatives.


 


6.8        Severability.
It is the desire and intent of the parties that the terms, provisions, covenants, and remedies contained in this Agreement shall
be enforceable to the fullest extent permitted by law. If any such term, provision, covenant, or remedy of this Agreement or the
application thereof to any person or circumstances shall, to any extent, be construed to be invalid or unenforceable in whole or
in part, then such term, provision, covenant, or remedy shall be construed in a manner so as to permit its enforceability under
the applicable law, to the fullest extent permitted by law. In any case, the remaining provisions of the Agreement and the application
thereof to any person or circumstance other than those to which they have been held invalid or unenforceable, shall remain valid
and in full force and effect.


 


[Remainder of Page Intentionally Blank]


 




    	4



    	 



    

 


IN WITNESS WHEREOF,
the parties have executed this Consulting Services Agreement as of the date first above written.


 





	COMPANY	 	 	CONSULTANT
	 	 	 	 
	SKYSTAR BIO-PHARMACEUTICAL COMPANY	 	 	R. Scott Cramer 
	 	 	 	 
	By: 	 	/s/ Weibing
    Lu	 	By:	/s/
    R. Scott Cramer
	 	 	 Weibing Lu	 	 	R. Scott Cramer 
	 	 	 	 	 	 
	Title: 	 	Chief Executive Officer	 	 	 







  




    	5